Anxiety, Pain
Conditions
Brief summary
This study will evaluate the acceptability, use, and general effect that exposure to virtual reality has on hospitalized patients reporting at least one discomfort including recent or current moderate-severe pain.
Detailed description
Patients with moderate-severe pain will be approached with approval of nursing staff and front line nurse manager who determine their appropriateness for a trial of virtual reality (VR) exposure for up to 30 minutes. The trial and use of VR will be explained after meeting the inclusion criteria and they will be asked about their level of interest in trying the VR headset. If interested, the subject will indicate their verbal consent to proceed with the VR trial. They will be asked about any baseline discomforts of pain, anxiety/stress or other discomfort; which will be rated on a 0-10 numeric (visual analog) scale. A baseline heart rate will be recorded in beats per minute. The headset will be applied and adjusted for comfort, then the app will be started along with a timer to track the duration of their use up to a maximum of 30 minutes. When the Headset is removed, the duration of use will be noted. The change in post-exposure heart rate (in beats per minute) and discomforts of pain, anxiety/stress or other discomforts (subtracting baseline from 5 minute post-exposure data) will be recorded. Subjects will be asked about the ease of use, whether or not they would use VR again, and for any other comments they would like to express. The headset will be disinfected between patient use.
Interventions
DEVICEVirtual Reality Exposure
Exposure to Virtual Reality program for up to 30 minutes
Sponsors
Massachusetts General Hospital
Study design
Observational model
OTHER
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
20 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
* English-speaking * Inpatients on a general care unit * Current or recorded moderate to severe pain in past 24 hours
Exclusion criteria
* Receiving palliative/end of life care; * Admitted for treatment of psychiatric or mental health disorder * History of seizure or stroke * Legally blind or deaf * Moderate or severe cognitive impairment * Head wounds or bandages * On isolation precautions.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in Pain | Change between baseline and 5 minutes after intervention | Change in subjective report of pain measured on a visual analog scale |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change in Heart Rate | Change between baseline and 5 minutes after intervention | Change in heart rate measured in beats per minute |
| Change in Anxiety | Change between baseline and 5 minutes after intervention | Change in subjective report of anxiety measured on a visual analog scale |
Countries
United States
Outcome results
None listed